Home/Filings/4/0001209191-21-041062
4//SEC Filing

Bregua Corp 4

Accession 0001209191-21-041062

CIK 0001817713other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 6:22 PM ET

Size

21.1 KB

Accession

0001209191-21-041062

Insider Transaction Report

Form 4
Period: 2021-06-15
Bregua Corp
10% Owner
Transactions
  • Conversion

    Series A Convertible Preferred Stock

    2021-06-15526,3160 total
    Common Stock (674,211 underlying)
  • Conversion

    Common Stock

    2021-06-15+1,138,6651,138,665 total
  • Conversion

    Common Stock

    2021-06-15+247,1233,690,427 total
  • Conversion

    Common Stock

    2021-06-15+674,2113,443,304 total
  • Conversion

    Series B Convertible Preferred Stock

    2021-06-15192,9140 total
    Common Stock (247,123 underlying)
  • Conversion

    Common Stock

    2021-06-15+1,630,4282,769,093 total
  • Purchase

    Common Stock

    2021-06-15$17.00/sh+58,823$999,9913,749,250 total
  • Conversion

    Series Seed Convertible Preferred Stock

    2021-06-15888,8880 total
    Common Stock (1,138,665 underlying)
  • Conversion

    Series Seed 2 Convertible Preferred Stock

    2021-06-151,272,7780 total
    Common Stock (1,630,428 underlying)
Footnotes (3)
  • [F1]Each share of Series Seed Convertible Preferred Stock, Series Seed 2 Convertible Preferred Stock, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") converted into 1.281 shares of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date.
  • [F2]These securities are held directly by Bregua Corporation (Bregua). Klaus Dorner is the Director of Bregua and may be deemed to have voting and investment power with respect to the shares held by Bregua and as a result may be deemed to have beneficial ownership of such shares. Mr. Dorner disclaims beneficial ownership of all shares held by Bregua, except to the extent of his actual pecuniary interest therein, if any.
  • [F3]The shares were purchased in the Issuer's initial public offering.

Issuer

Janux Therapeutics, Inc.

CIK 0001817713

Entity typeother
IncorporatedVirgin Islands, British

Related Parties

1
  • filerCIK 0001863287

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 6:22 PM ET
Size
21.1 KB